Skip to main content

Exploring the Role of Antiviral Drugs in the Eradication of Polio Workshop Report (2006) / Chapter Skim
Currently Skimming:

Appendix C: Workshop Agenda and Participant List
Pages 69-72

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 69...
... Polio eradication plan update Looking ahead to the end-game: Bruce Aylward Strategies for the OPV cessation era: Roland Sutter Potential roles for an antiviral: Mark Pallansch 10:15 a.m. Overview of poliovirus biology and pathogenesis Eckard Wimmer 69
Read the entire page →
From page 70...
... Public Health group: How would the drug be used in eradication? Who would patients be, how would they be identified and reached?
Read the entire page →
From page 71...
... Walter Dowdle, The Task Force for Child Survival and Development Ellie Ehrenfeld, NIAID, NIH Diane Griffin, Johns Hopkins Bloomberg School of Public Health Matthias Gromeier, Duke University Medical Center Neal Halsey, Johns Hopkins Bloomberg School of Public Health Stephen Hughes, National Cancer Institute Kristin Kenyan, CDC Karla Kirkegaard, Stanford University School of Medicine Mauricio Landaverde, Pan American Health Organization Catherine Laughlin, NIAID, NIH Mark McKinlay, Gentara Corporation Philip Minor, National Institute for Biological Standards and Control, UK
Read the entire page →
From page 72...
... 72 ROLE OF ANTIVIRAL DRUGS IN THE ERADICATION OF POLIO Akhter Molla, Abbott Laboratories Mark Pallansch, CDC Amy Patick, Pfizer Olve Peersen, Colorado State University Jane Seward, CDC Tim Skern, Medical University of Vienna Roland Sutter, WHO Kimberly Thompson, Harvard School of Public Health Linda Venczel, CDC Margie Watkins, CDC Jerry Winkelstein, Johns Hopkins Children's Center Peter Wright, Vanderbilt University School of Medicine Staff from the National Academies Board on Life Sciences Ann Reid, Study Director Anne Jurkowski, Program Assistant Fran Sharples, Director, Board on Life Sciences
Read the entire page →

Key Terms

  • hopkins bloomberg
  • catherine laughlin
  • stephen hughes
  • nih diane
  • health stephen

  • bruce aylward
  • center neal
  • drug evaluation
  • philip minor
  • american health

  • list jim
  • kristin kenyan
  • organization catherine
  • roland sutter
  • matthias gromeier

  • amy patick
  • gentara corporation
  • cdc karla
  • mauricio landaverde
  • mark mckinlay

  • diane griffin
  • corporation philip
  • nih mark
  • ellie ehrenfeld
  • marc collett

  • medicine mauricio
  • participant list
  • child survival
  • pan american
  • neal halsey


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.